denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
Program: Scientific Workshops
Session: Background to Virally Driven Lymphoproliferative Disorders
Program: Scientific Workshops
Session: Background to Virally Driven Lymphoproliferative Disorders
Friday, December 8, 2023, 2:03 PM-2:43 PM
Disclosures: Heslop: Tessa Therapeutics: Membership on an entity's Board of Directors or advisory committees, Other: Research Support; Marker Therapeutics: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees; Ankyra Therapeutics: Membership on an entity's Board of Directors or advisory committees; Allovir: Current equity holder in private company; Fresh Wind Biotechnologies: Current equity holder in private company; CoRegen Inc.: Current equity holder in private company.
See more of: Background to Virally Driven Lymphoproliferative Disorders
See more of: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
See more of: Scientific Workshops
See more of: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
See more of: Scientific Workshops
Previous Presentation
|
Next Presentation >>